The number of blood samples drawn from glioblastoma patients operated at BWH was estimated to be 3.7-fold higher compared to patients from UMCU after correction for age, sex, IDH1 mutation status, postoperative KPS score, length of stay, and survival status (Table 2). This evidence concerns the gene IDH1 and glioblastoma.